VEGFA and neoplasm: Combination treatment with an anti-mouse VEGF antibody improved the CAR-T cell infiltration and distribution throughout the TME, delayed tumor growth, and improved the ability of CAR-T cells to penetrate and distribute throughout the TME compared with CAR-T-cell therapy alone.